Q4 2022 ModivCare Inc Earnings Call
[music].
Good morning, and welcome to motive Care's fourth quarter and full year 2022 financial results Conference call. At this time, all participants are in a listen only mode.
A question and answer session will follow the formal presentation, if you'd like to ask a question. Please press star one on your telephone keypad. Please note that this conference is being recorded I will now turn the call over to Kevin Alice <unk> head of Investor Relations. Thank you. Please go ahead.
Good morning, and thank you for joining motive curious fourth quarter and full year 2022 earnings conference call and webcast joining.
Joining me today is Heath Sampson motor carriers, President Chief Executive Officer, and Chief Financial Officer, Ken Shepard, CFO mobility, and Scott <unk> CFO at home.
Before we get started I want to remind everyone that during today's call management will make forward looking statements under the private Securities Litigation Reform Act. These statements involve risks uncertainties and other factors that may cause actual results or events to differ materially from expectations.
Information regarding these factors is contained in today's press release and in the company's filings with the SEC.
We will also discuss non-GAAP financial measures.
Additional information to investors a definition of these non-GAAP financial measures and to the extent applicable Ah reconciliation to their most directly comparable GAAP financial measures is included in our press release and form 8-K.
A replay of this conference call will be available approximately one hour. After today's call concludes and will be posted on our website motive care dot com.
This morning Heath Sampson will begin with opening remarks.
Then he will provide an update on our business strategy and review highlights of our fourth quarter and full year 2022 results.
And Shepherd will review, our financial results and outlook for 2023.
Then we will open the call for questions.
With that I'll turn the call over to Heath.
Hello, everyone and a warm welcome to our fourth quarter and full year 2022 earnings calls.
Today, we reported strong full year 2022 results with revenue and adjusted EBITDA exceeding the high end of our guidance ranges. These results were driven by solid growth in our mobility business and now double digit growth from our home Division, which includes personal care service.
<unk> and remote patient monitoring.
I want to take a moment to acknowledge and express my appreciation for the hard work and dedication of the entire team at motive care.
Because of them that we are able to provide high quality care and the best experience for our approximately 35 million members.
We ended the year with solid momentum heading into 2023.
To this point, we issued 2023 revenue guidance of 2.5, 75 to $2 6 billion and adjusted EBITDA guidance of $225 million to $235 million, indicating our confidence in continued growth.
Yeah.
In the past two quarters, we have taken significant steps to realign and reallocate resources to drive efficiencies and operating leverage.
One motive care strategy, which is defined as the alignment across all of our supportive care services will help us share best practices drive scale inefficiencies and standardized processes to ensure the best experience for our members and our customers within each point solution and more.
Holistically across all of our solutions.
Our goal for 2023 is twofold.
Built for scale and grow our business.
To build for scale, we will strive for operational excellence integrate its one motive care and.
And use technology to enable our solutions.
To grow we will sell our point solutions more effectively.
Leverage our relationships to cross sell.
And continue to deliberately develop and grow our value based care solutions.
Our approach to value based care is about driving performance based payments into each of our point solutions and eventually moving into more shared risk arrangements across our entire platform.
Okay.
I'd like to discuss some exciting advancements from our innovation efforts.
Our remote patient monitoring solutions like E. Three are the tip of our spear for value based care and we are seeing increased activity from payers, who want to sign up new arrangements with us.
We recently began an innovative value based care program for E. Three with a leading national managed care organization. This program is essentially the next evolution of E. Three as it utilizes greater data sharing in partnership with the health plan for gap closures and necessity.
Allowing us to have a more meaningful impact on improving outcomes and using our supportive care services.
We are in discussions with several other national payers for similar programs and we continue to look for ways to build off our innovative programs and point solutions shifting from standard benefits to Medicare advantage supplemental benefits.
We are confident about adding more value based care arrangements to our portfolio.
And using valuable member data insights and analytics to drive meaningful long term value for all of our stakeholders.
Our new sales organization has made very good progress.
We have a lot of exciting plans for the year to accelerate our growth. Although most of this sales success will increase revenue in 2024 and beyond.
Our sales pipeline has increased by over one third and we are close to signing contracts with new customers that we historically did not pursue.
Before I dive into our segment highlights for the quarter I wanted to update you on some of the changes we made to our leadership team. We've hired some great people, including an SVP of strategic execution, Matt Snyder.
And then S V P of innovation and growth Seth Rubin.
And we have even more exciting announcements soon to come.
But as you can imagine it takes time to find the right people for the job.
As we have adjusted our operating model and priorities it had been necessary to make some personnel changes.
I want to thank those who are leaving us for their hard work.
But I'm confident that we're putting together the best team to take motive carrier to the next level.
Okay.
Moving on to our mobility or any Mt's segment I'm pleased to report that we experienced a 14% year over year increase in A&P revenue during the fourth quarter.
This growth was driven by increased trip growth.
Membership grew to approximately 35 million members, which is consistent with our commentary from the third quarter earnings call.
Our focus on disciplined execution and kingdom alignment is working well.
For example, our fourth quarter on time performance was at its highest level in two years.
We also exceeded service level expectations in our contact centers.
Reduce mis trips by about a third.
We continue to transform our mobility operating model through three main initiatives.
Ryder partnership.
Multimodal network.
Omnichannel member engagement.
Our provider partnership initiative involves narrowing our transportation network and creating win win relationships with only the best providers.
Our multimodal network initiative medically tailors the members right.
A traditional sedan rideshare public transit or a family member.
And our only channel member engagement initiatives meet the members where they are.
By providing telephonic I V. A IV are texting chat.
Portal or App engagement.
Today, our primary engagement channel, it's telephonic as such we have a lot of opportunity ahead of us.
All three of these initiatives will further improve the member experience, while also driving down operating and trip costs.
We had significant improvement in our operating performance in the fourth quarter and we expect the initiatives we have implemented to have meaningful impact throughout 2023 on both our member experience and cost structure.
Regarding redetermination, we acknowledged that Medicaid members can be reviewed by states starting April 1st House.
However, states are obligated to fulfill various reporting and outreach obligations, which could cause delays in the process, especially in the states, where we have significant presence.
We expect the impact of this process in 'twenty, two 2023 to be insignificant.
We have outlined strategy such as contract repricing.
This win and operational enhancements as discussed earlier.
And at our Investor Day in June , which we believe will enable us to overcome any long term impacts.
Moving onto the home division, which is comprised of our personal care and remote patient monitoring segments in the fourth quarter, our personal care revenue grew 12% year over year as we continued to see strong improvement in caregiver hiring trips.
We recently implemented a caregiver satisfaction score across our organization similar to our net promoter score.
We improved our caregiver satisfaction by over 50 points in 2022 to the great level by capturing feedback through our caregiver Advisory Council and by providing additional Devin benefit the jazz 401k.
What benefit and an employee assistance program.
While we improved our score last year, we know that we can even do better and we aim to achieve excellent mark in 2023.
All these investments in our team members' experience has helped us maintain an industry leading retention rate of 65%.
Our main goal is to achieve growth in the personal care sector to achieve this we are continuing the heavy lift to standardize and centralize dawn caregiver functions and certain operational processes by doing this we aim to create a more efficient and scalable platform.
For growth.
Our strategy also involves focusing on our efforts on developing standard tools and techniques that can be deployed locally to accelerate caregiver recruitment and retention.
In addition, we plan to expand our personal care locations through de novo openings and position ourselves to easily integrate any future acquisitions.
We expect the reimbursement environment to remain favorable for personal care services, and we plan to add more value based care arrangements.
Her to our current value based care arrangements in Pennsylvania focused on gap closure.
We have also added new arrangements focused on changes condition escalation as well as electronic visit verification or E. B b.
Moving to a remote patient monitoring segment.
Which is a particularly innovative and important part of our business we.
We saw strong growth during the fourth quarter with monitoring revenue, increasing 18% year over year and adjusted EBITDA margin of 35, 8%.
We saw 36% year over year increase in total active clients in the fourth quarter, which includes the contribution from the integrated Guardian medical monitoring acquisition.
Our monitoring team performed exceptionally well last quarter with a couple of new state Medicaid wins, and a strong pipeline for additional business that we can execute on this year.
Our net promoter score also remained at an industry leading 88.
As we move into 2020 three our priorities are to accelerate Medicaid and Medicare advantage sales and continue to innovate our monitoring offerings and value based care capabilities.
We expect growth in line with our long term target of mid teens revenue growth and a mid 30% adjusted EBITDA margin.
Before I turn the call over to Ken Shepherd, our CFO from ability to review the fourth quarter and full year 2022 financial results I want to remind everyone that the biggest fundamental challenges facing the U S health care systems today are at elevated costs.
The inequities and access to care for the most vulnerable patients.
And two little focus on care prevention by addressing the socially terms of health.
We are uniquely positioned to address these challenges.
Our supportive care solutions provide the highest quality best in class member experience in the most cost effective manner for our customers and the health care system as a whole.
Ken Please walk us through our financial results.
Thanks Heath and good morning, everyone.
We had a strong year in 2022 with consolidated revenue of $2 5 billion up 25% year over year, driven by double digit growth across each of our segments.
Net loss from continuing operations in 2020 two.
It was approximately $32 million or $2.26 per share.
Adjusted net income for the year was approximately $103 million or $7.32 per diluted share and adjusted EBITDA was approximately $222 million or eight 9% of revenue.
For the fourth quarter revenue increased 14% year over year to $654 million net loss from continuing operations was 7 million or <unk> 49 per share.
Adjusted net income for the fourth quarter of 2022 was approximately $30 million or $2 11 per diluted share.
Fourth quarter, adjusted EBITDA of approximately 60 million or nine 1% of revenue.
Fourth quarter adjusted EBITDA included approximately $7 million of one time benefit about half of which was related to our year end accrual adjustments and the other half related to a onetime revenue recapture and our any empty contracts.
Excluding this benefit adjusted EBITDA for the full year would have been near the midpoint of our guidance range, which we think is a good baseline when thinking about growth in 2023.
Transitioning to the financial results of our segments, starting with mobility or any M. T fourth quarter 2022 revenue increased 14% year over year to $459 million driven by a 16% increase in average monthly members.
For the full year, and Emt revenue increased 19% year over year to $1 $77 billion, driven by a 14% increase in average monthly members and a 4% increase in revenue per member per month.
Service expense for the IMT segment, which includes all direct costs increased approximately 22% year over year in the fourth quarter of 2000 $22 million to $387 million.
The increase was driven by higher service expense costs associated with higher trip volume related to increased monthly membership and a 13% increase in transportation cost per trip due to the general inflationary environment on.
On a sequential basis purchased services per trip were flat at $42 per trip.
Utilization, which is defined as monthly paid member paid trips per member was.
Flat quarter over quarter at seven 5%.
That said, we expect utilization to gradually increase throughout 2023.
M. T. Net income was $17 million in the fourth quarter of 'twenty, 'twenty, two and approximately $79 million for the full year.
E M T. Adjusted EBITDA was approximately $46 million in the fourth quarter of 2022, or 10% 10, 1% of many empty revenue.
Full year any M. T. Adjusted EBITDA was approximately 169 million or nine 6% of any empty revenue.
Any empty margins for the fourth quarter and full year were lower primarily due to higher transportation costs.
Partially offset by G&A cost leverage.
While we experienced higher transportation costs throughout the first three quarters of 2022 we expect cost per trip to stabilize and gradually improve in 2023.
Turning to our personal care segment revenue in the fourth quarter of 2022 was $176 million, which was a 12% increase year over year.
We saw increases in caregiver hiring throughout the quarter. However, we typically see a seasonal slowdown in hours in December around the holidays.
This resulted in fourth quarter hours remaining flat sequentially at $6 8 million.
Which was still an improvement from typical Q4 seasonality as we typically see hours declined in the low single digit range from Q3 to Q4.
Full year 2022 personal care revenue increased 35% year over year to approximately $668 million driven by the full year contribution from our care finders acquisition, which annualized in September.
As well as improvements in recruiting retention and a 6% revenue per hour increased during the year.
Personal care service expense per hour, primarily representing caregiver wage expense increased approximately 6% sequentially from the third quarter of 2022 due to increased wage expenses, particularly in New York, where there was an increase in caregiver minimum wages and a key.
Corresponding reimbursement rate increase during the fourth quarter.
Going forward, we expect caregiver wage inflation to continue to be offset by reimbursement rate increases.
Personal care segment net income was $2 $3 million, while segment adjusted EBITDA was $16 $6 million in the fourth quarter of 2022 or nine 4% of revenue.
For the full year personal care adjusted EBITDA increased 67% year over year to approximately $70 million, which was 10, 5% of personal care revenue.
While we were able to drive some G&A leverage during the fourth quarter higher service expense led to a 160 basis point sequential decrease and adjusted EBITDA margin.
Moving onto our remote patient monitoring revenue in the fourth quarter of 2022 increased 18% year over year to approximately $19 million, which included approximately $4 $6 million of contribution from our Guardian medical monitoring acquisition.
For the full year remote patient monitoring revenue was 68 million, which included approximately $12 million of contribution from Guardian.
On a sequential basis average monthly members increased approximately 3% driven by consistent growth and referrals across the legacy and recently acquired RPM business.
R. P. M segment net income was zero point $7 million in the fourth quarter, while adjusted EBITDA was approximately $6 $8 million and adjusted EBITDA margins improved 50 basis points sequentially to 35, 8%.
We remain confident in our long term targets for RPM revenue growth in the mid teens and margins in the mid 30% range.
Turning to our cash flow and balance sheet consolidated cash flow from operations in the fourth quarter of 'twenty 'twenty. Two was the use of $56 million due to payments on contract payables, partially offset by solid cash flow from our core operations.
During the fourth quarter, we reduced our contract payables balance net of our contract receivables by $61 million to a net balance of $123 million.
For all of 2022, we reduced our net contract payables by $134 million, which primarily relate to overpayments in liability reserves uncertain any empty contracts.
Excluding the combined negative impact of $61 million from these items during the fourth quarter cash flow from our core business remains solid.
As a reminder, we expect more normalized level of activity for these contracts payable moving forward and therefore, a more normalized environment for our free cash flow in 2023.
We ended the fourth quarter of 2022 with approximately $14 $5 million in cash and had no amounts drawn on our $325 million revolving credit facility.
Our principal debt balance was sequentially flat at $1 billion and our consolidated pro forma net leverage was four three times as of December 31 2022.
We met we remain committed to delevering overtime, and our target net leverage ratio of three times remains unchanged.
In 2020 three we expect net leverage will be gradually reduced to the high three times range through debt reduction and EBITDA growth.
As a reminder, 100% of our current debt structure is at fixed rates.
Our capital allocation strategy remains unchanged as we are committed to a disciplined and balanced approach towards capital deployment.
With a primary focus on Delevering our balance sheet.
This morning, we provide 2023 guidance setting.
That included revenue in a range of 2.5, 75 to $2 $6 billion and adjusted EBITDA of $225 million to $235 million.
Here are some of the puts and takes to consider as you think about the year ahead.
Within our home Division, which includes personal care and remote patient monitoring.
We expect revenue and adjusted EBITDA to increase double digits on a combined basis in 2023.
For personal care, we expect high single digit to low double digit revenue growth driven by continued improvement in the caregiver hiring.
Leading to growth in hours, along with reimbursement rate increases.
For remote patient monitoring we expect revenue growth in the mid to high teens.
Driven by new client growth. We also expect to see increased utilization of our suite of monitoring services led by our E. Three engagement solution.
In our mobility segment, we expect revenue and adjusted EBITDA could approximately be flat in 2023.
Well, we've had several new any M T wins in 2022 the timing of our larger opportunities has been pushed out to the extent that we don't expect a meaningful impact in 2023.
Our contract pipeline is as strong as ever and we are confident that we will continue to win our fair share of competitive contracts going forward.
We also believe that the impact from Redetermination in the second half of the year and normal attrition could be a headwind.
Which could offset potential wins contract expansions and re pricings that are expected in 2023.
As we suggested last quarter, we expect our full year 2023, adjusted EBITDA to be more back half weighted due to our ongoing operating initiatives.
Two financial results.
We are confident that 2023 will build upon the progress that we've made in 2022, and we look forward to reporting meaningful progress on our operation on strategic initiatives over the next several quarters.
I would also like to take this opportunity to thank the entire team at motive care for the hard work and dedication throughout the year to generate these results, while providing high quality care improving health outcomes for our members.
This concludes our prepared remarks, operator, please open the call for questions.
Thank you the floor is now open for questions. If you would like to ask a question. Please press star one on your telephone keypad at this time a confirmation tunnel indicate your line is in the question queue. You May press start to if you would like to remove your question from the queue for participants using speaker equipment. It may be necessary to pick up your handset before pressing the star keys.
In the interest of time, we do ask you. Please limit yourself to one question and one follow up again that is star one to register a question at this time.
The first question today is coming from Brian Tranquility of Jeffries. Please go ahead.
Okay. Good morning, guys, then congrats on solid quarter.
Yeah <unk> is there anything about cash flows obviously you <unk> you know there was Catherine you Fork that was expected, but how should we be thinking about cash generation going forward and and the rebate is that an issue that's behind us at this point.
Yeah, Yeah. So just so so consistent with what we've been saying for the last four quarters.
2022 involved paying off the.
Cash that we accumulated on our balance sheet through Covid and 2020 and 2021.
Bulk of that the accumulation or are disproportional amount of that accumulation was all paid off in 20 twenty-two soda the COVID-19 pay.
Pay off was was finished in 2022 and that was the main driver as you can see it are but a 50 million dollar decrease quarter over quarter.
That we paid above and beyond are kind of normal working capital fluctuation.
The other item that just to note for everybody when repair our our debt as well we pay 70 annually. So that also happened in this quarter. So those two reasons are the main reasons of why we are for it for cash and then and.
And then get for your question going forward now we're at normal levels of of working capital and we expect to be generating free cash flow each quarter going forward.
Awesome, and then I'd like to think about any empty business, obviously, it was pretty strong queue for.
The past you've talked about redeterminations being a headwind for this year and you've you've even quantify that but how should you be would you be thinking about margins for N E M T.
Over the course of the year and also has been normalized post read determinations.
Yeah, so margins for 2023 and going for will be on the lower end of our range as we work through the transition of mainly mainly to reason for that and it has primarily do with costs.
Last Q3, and Hu for really hit the high Mark on our unit cost within the.
The mobility segment, primarily driven by the pressures that everybody's feeling that we've been feeling around inflation.
Fuel.
That in general However, we expect that to start coming down in the latter half primarily because of these initiatives. We have in place, which is mainly involving narrowing our network to the key providers. Therefore, assuring that we we can pay them the right level of unit cost at a higher level so hit the high water.
That will come down but that would be the latter part of this year. In addition to that in our operating expense, which are a big chunk of that has to do with the calls we take the majority of the interactions we have with our members still are telephone.
And and we're doing a kind of common <unk>.
Practices around call avoidance, whether that's text messages apps those two things will allow us to to reduce the cost increase remember experience and I expect us to start moving to the middle part of the range of our expectations and then in 2023.
Awesome I'll drink back in queue. Thank you. Thanks.
Thanks.
Thank you. The next question is coming from Bob lay back C. J a securities. Please go ahead.
Hi, Good morning, it's Pete Lucas for Bob you guys covered a lot answered the most of my questions. Here. Just if you could give a quick update on labor conditions and staffing levels. Some personal care what are the expectations for the year and how much closer to do you think you can get to pre pandemic levels and in terms of any improvement you're seeing.
[noise] and hiring and are making to achieve those calls.
Yeah. So the the amount of work that we've done in the personal care segment led by me and Haney. There has been tremendous and it really is transforming that organization, where we have these hundred plus locations that are really used to doing everything from the beginning to the end on on how you deliver the service and how you have an account for.
We've made a lot of progress and and centralizing in standardizing a lotta those.
Halfway through that journey 2023 is a big part of that.
Those efforts, we had some investments that we needed to make out that corporate level and we'll start to see those investments pay off as we finish with that with that integration, but the point the point around that is that frees up.
The the resources, whether that's the body or even capital to ensure that we are properly investing in our caregivers with increased pay or as importantly, and in some cases more importantly, giving additional benefits to ensure that we can recruit and retain so that that is showing up in the in in our.
Recruitment and retention numbers, we have grown relatively consistent with the high performing players within personal care. So very successful made a lot of progress so the labour challenges.
Stabilized and we expect it to stay.
At that stabilized level.
And then the initiatives that I've, just articulate before it's gonna allow us to really accelerate beyond the market and recruiting and retention as we as we noted as well earlier, our retention rates are high higher higher than normal so labor in a good spot always going to be challenging hiring hourly people in specific caregivers. So.
But we feel good about where we're goin' pre pandemic levels were not there yet from a standpoint of meeting that demand I think that's related to your question.
And that will we won't we won't get all the way back to that even at the end of this year, but we will have significant growth. So the point of that is I think we have a reasonable plan and.
And then and then after that I do think will continue to accelerate beyond that but so that's kind of the update on the labor market and what we're doing to to push beyond that.
Extremely helpful. Thanks, I'll jump back in the queue.
<unk>.
Thank you. The next question is coming from Brooke's O'neill uptake Street capital Partners. Please go ahead.
Well good morning, I hate that I have a couple of questions I guess.
First I'd love to hear a little bit more about the response state governments and managed care companies said the one.
Mode of care, an issue that you discussed in your prepared remarks.
Yes, so so yeah, the the the one that motive care vision.
Resonating well with and with all our pairs and even internally for us, it's allowing us to work risk cross mostly across all of our division. So.
It's really resonating with the senior.
Sea level people within each each of these specific pairs or states and why is that because they're having the same challenges and struggles within within their patient population. It's all about how do they identify the higher risk people and get ahead of that the one they can help them and also kind of low.
That cost of care and.
Almost every week or every month. There is some study that comes out around the benefits of supportive care services and the direct impact that had on changing outcomes. So that acceleration that data is really resonating with executive and we are.
We are we are in front of a lot of clients either doing pilots right now doing contract work, where we are actually helping them change outcomes and then even in broader discussions and how we bring them all together to help their population. So long story short resonating very well.
And we expect our contracts to increase this year round that and then and then do a lot of work to ensure that that continues to happen.
Fantastic.
I I think it's a great initiative. So let me just ask one more I see some activity in the personal care Ah Ah Rita.
Guess I might call it consolidates an activity, but it's really bored.
Various corporate excuse me what's happening.
I see that as the opportunity or a threat to you in the personal care arena.
So so the personal care.
Industry as a whole continues to mature.
And then you know.
Still made up primarily mom-and-pop organizations, you know 150000, plus so it's a normal cycle of almost every industry industry that goes through that that consolidation, but more so impersonal carry that this gets back to you or even your previous question the value of the services for People's members are.
Evil and that is that shows up in our increase reimbursement rates. It shows up in increased regulation by the way, which sounds like a bad thing, but it's actually a good thing so you're seeing more sophisticated.
People realize that and continue to roll that up and consolidated.
So I view the the what's happening in the marketplace as a positive thing for the industry as a whole and there's plenty of hours out there and I expect and hope that that that continues so not a not a threat I think good for the industry.
And I expect that to continue.
Perfect. Thank you very much.
Thank you. The next question is coming from Scott Fidel of Stevens. Please go ahead.
Hi, Thanks, Good morning first of all I should just interested just interested if you've got you've got any insights into just how matrix has been doing with their operational turn around and then then I know that you've talked about you know potentially seeing an opportunity to looking out to the back half of twenty-three more monitor so.
<unk> opportunity just interested in in your updated thoughts shop around that spot potential catalyst.
We're we're really proud of what matrix. It's done over these last six to nine months I'm completely new management team.
Restructuring divestiture of businesses that really pops in COVID-19, but the thesis of them continuing post COVID-19 was not there. So a lot of heavy lifting to to get those away and not be a distraction and then even take out the cost.
That are related to that pretty much done with all of that restructuring costs and then and then more importantly, this gets to the team that they brought in the.
The levels of performance within the risk adjustment business, they're back to the way it was pre COVID-19 Unfortunately kind of lost.
Focused on that in in those kind of 20, 2020, 2021, and even cause the early part of 2022, but they're back and increasing beyond that that's tech process new people. So I'm really encouraged about what they've been doing they're showing up in the numbers and I expect that to accelerate and the related financial performance.
<unk> to continue to improve each quarter, you know I know I've said that that potentially there is something in 2023, and I think that could happen really for us and what we're seeing now is watching them perform in helping them perform and again the monetization will be there I still think thats early it's would be.
2023, but yeah. So we look forward to watching them do it and and that's at the right point in time, though there'll be there'll be an exit for us.
[noise] understood and then just stop my final question, just getting back to Redeterminations and obviously, that's a trickier sort of modeling exercise for all of US until we just see the Tampa starting to kick in does sound like you're building in some mixer packed right in terms of assuming some.
Higher utilization in 2023, which I think seems prudent you would be interested in sort of how you're you're modeling and average membership you know just as we sort of play out over the course of the quarters, just as we factor and and think about redeterminations. Thanks.
Yeah, So you're right.
We expect that to what we have models into our numbers that coming down membership coming down in Q3 Q for but we also do have offsets with with other new ones that were doing expansion of certain port pillows that we do have so that's why we're saying we think it's it's something we'll be able to manage through.
And I also do think if it does start happening in Redetermination.
Our motto is probably a little conservative for what's likely to happen. If you talk to and I know Scott you talked to everybody a lot around us.
The the requirements and the appropriate requirements for state.
What they have to do before they were all people off or.
Our laborious and detailed and I and I do think that's going to take some time and and I do think we'll figure out the a lotta people pricey. So again I think it's.
Remodel it I think it's conservative, but the way it is in our motto offsetting a good chunk of that with with new rock new volume of new business in the latter half of this year.
Okay, great. Thanks.
Okay.
Thank you. The next question is coming from Peter check or if Deutsche Bank. Please go ahead.
Hi, there. This is <unk>, taking the question how's it going guys can I start off with with guidance. It looks like the margin assumptions and guidance are about $8, 69.1% versus you know 8.9% in 2022.
Thank you for giving us some good color on the top line growth across the businesses, but is there any key expense swing factors that you would call out between <unk>.
Hello, and high end of Breenge, whether it's you know wage growth turnover transportation costs like is there anything that sticks out more than the others.
Yeah. So so.
A couple of things getting back to mobility, and where we are in the in the lifecycle of the initiatives that we are doing.
The cost structure with mobility at the high point right now both on the unit costs. So in our fog as well as in that operating expense side and and we expect those to start coming down in the latter part of this year, so that cost structure tie and again, if it's not rolling off to the engineer for.
Full year still remained elevated to how will you be accident. So that's one explanation for with a margin that we have in the personal care business and deliberate and absolutely. The right thing to do and I said. This is a little bit earlier is is we're moving into this new model, where we have back office centralize.
<unk> as well as other processes.
In the operations actually centralized we're investing in that now and.
And the reason why we're doing that now could we need to catch the changes that were making with the people and that cost shift.
Basically getting the other costs will also start happening the latter part of this year and it makes a lotta sense or ability ended up centrally but as we finish with the integration into the right deliberate way with people process and tech will be able to lower that operating costs in the field I'm in the latter part of this year. So.
[noise] again, we're probably at the high point from a cost perspective, and the personal care segment, aside and I expect that to improve in an accident, India b on the higher end of hard range from a from a margin perspective exiting 2023 really the same with monitoring as well written that were for us to focus and the opportunity is all about.
Selling margins are very strong we are getting minimal leverage on the G&A side, I expect that and improve normally this year and then 2024 beyond so the other thing that we are doing and any of you can see this if you. If you look at our our our add backs we are ensuring that we have the right people and the right.
And a part of that with what I talked about earlier around how we were investing in different parts of the business. We're also releasing people and we did that and we did that in Q4 and I expect that to happen as well going forward to ensure again that we have the right people and <unk> all that putting aside.
If you're really comfortable with the margin ranges that we have in 2023, and you feel really comfortable about our cost structure and left and leverage from the people, we get going beyond that.
Comment that I would add is.
You take out what we mentioned on the call the $7 million of one time benefits that we experienced in the fourth quarter.
The margins will be right at that low ended the eight six to nine one for 2022.
And so really we feel like the jumping off point is is appropriate and so we feel like we have upside opportunity in 2023.
That's very helpful. Thank you and just a quick follow up you touched on RPM. There you know top linger is holding up well, but you know the.
Not as quite as much DNA leverage there.
Would you attribute most of that just got into these contracts Repricings that you talked about last quarter and then I know, there's some negative pricing impacts from the Guardian acquisition and to get back to you know a point, where you are generating operating leverage and EBIT is growing faster than revenue.
That kind of just those dynamics just need to annualize out or is there. Some other factor there that we should look for that yeah, yeah. So I'll. Thanks.
The Guardian actually has.
The pricing right in line with the rest of it so it hasn't been.
Not a drag the Guardian acquisition really successful integrated we are getting leverage off of that from Ah just within the RPM grew.
Groups so I.
Congratulations to the team that's really successful and it's good for us.
On the pricing side and definitely related to the margin that we had it coming into even torn into 2022 is this is the.
The M. A pricing that we had for a large pair deliberately doing that because we're getting a national.
License to hot so I'll do that every day all day for him a business, but that's the main reason for the Delta and the decrease in margin, it's because of the business that we brought on but that again that will help grow the dollar amount going forward. So so that I'm really excited about that for us.
It's really about growth and ensuring we're growing that business as a whole margins are still strong, but those those lower levels or on purpose and as expected and I will continue to do that if necessary on the side and then leverage on the G&A side I don't want to overplay that because they are they are still performing well I've just.
The point there is I do think there's an opportunity to get to get more leverage around the one motive care G&A platform as well, but we're just we're prioritising stuffing in right now that's that that we're fine with where we are now so long story short great margins on purpose based on the business and I.
Expect that to to continue for 2000 twenty-three beyond.
Thanks, so much.
Thank you. The next question is coming from Brian to include that if Geoffrey's. Please go ahead.
Hey, guys. Thanks for letting me do a follow up here. He is I think about the longer term guidance range. You had previously provided say for 2025, both in revenue and EBITDA I think about where you are for 23.
It implies a little bit of acceleration, I'm, 24, and 25 or either that or conservatism in twenty-three right. So anything you should you want to call. It call out for us that we should be thinking about that would drive some growth acceleration next year, and then valley ears.
[laughter].
So the the.
The growth within the home Division is very reasonable if you look at where we are and what we expect to have and those are really in line with what we talked about last June in line with the market in line with just kind of steady performance, where most where where the additional growth really needs to happen for us and I'm comfortable and this is in the <unk>.
T business and and primarily that has to do with selling so there's two dynamics around what has happened.
In the in the empty business and why I feel comfortable with that with that.
Celebrated bumped going into 24 and 25, one is the really the pushback of many large RFP.
And I think if you're talking about these rfps for 12, plus months and every month I'd say, they keep getting pushed out many of them and pushed out for a year.
And so this year the latter part of this year a lot of these larger or peace will come up and we expect to win more than our fair share of those but that volume won't come on until 2024.
So so the other half of that is Sally so our focus we've we've hired hunters right. We have great account management people, but we've also hired hunters and.
Our focus in the past hasn't been on the.
Growth beyond a really our current big clients that is our focus and there's a lot of other quite we we focus on the big six we know there's many more big payers out there and we are really close to signing a large deal with a large pair that we we haven't even talked to you before we didn't talk to before.
So in the pipeline is is that we articulated is significantly opposites kind of the August September timeframe. So those two together hunting coupled with the timing of large rfps, winning our fair share will allow us to hit those growth targets and mobility and therefore the growth targets across the.
Company, it's a hole through 2025.
Oh, that's awesome helpful very helpful. Thank you.
Thank you. The next question is coming from Mike.
Like to ski a farrington research. Please go ahead.
Good morning, I just want one.
Real quick one and then maybe possibly one one or two others on the payables issue I, just Wanna make sure Ah, you're essentially saying the the impact sort of completely not way reduced but the impact on cash flows and twenty-three is essentially X status is that is that.
A fair.
Characterization of what you're saying well so yeah. So there's a couple of things there was a little like always there's a little more more I should explain the consistent with what I said before anywhere kind of that kind of $40 million to $60 million paid out that is unusual that happened in 2022 that happen. When you see that happen in 20, guys you see that happened in the fourth quarter, we are still see.
In certain contracts that still that increased a little bit. So there there there is going to be some a little bit of lumpiness in our contracts payable for a few contracts I don't want that to distract from the message that I've been consistent he said I said earlier.
That we're back to normal working capital and that kind of big Covid bump is behind us, but there is a little bit that we will still be working through increases and then therefore, some lumpy decreases in the next couple of quarters, but not to the extent of the $40 million to $60 million each quarter.
Okay. So I mean it.
And I'm not trying to put words in your mouth, but just just in terms of magnitude I mean, it could be maybe you know sort of.
You know 10, or 20 million something like that over the course of the year in terms of drag, possibly or yeah. Yeah. That's the right way to box. It in okay. Okay perfect perfect and then on on the contract push out and then he sort of seemed to allude that there could be some attrition in the second half, which I'm assuming is around you know existing.
Yeah, obviously attrition existing relationships I guess can you sort of size up I mean, you know in any way the the contract size that you know in the aggregate that had been sort of been pushed out in your mind and and and also sort of the.
Potential attrition risk in the second half associated with transportation. Thanks, Yeah. So I don't see this.
Second half, having incremental attrition I think what's in our what's in our current numbers right. Now has the you know we continue to win world beyond what we've we've won and we so we are continuing to get new volume, but we haven't got the increased volume that we've that we expect.
That's the main message and again I don't expect any more attrition.
Happening and Q2 Q3 Q for what.
In our numbers right now is in our numbers I expect to actually win in the latter part of this year, but you're right that wouldn't come out until 2024. So I don't want a I want I'm glad you asked that question.
Question because.
I don't expect additional nutrition happening.
But we're so then from a size perspective, the good thing with US there's nothing that is material as a standalone right because we don't want to have the the risk or or.
On the other side, we don't have the opportunity either for us to really get one contracts and it's gonna have them meet a material impact that being said there are large contracts that that can have.
An annual evil doer range of kind of.
$5 million to $10 million, which is very good but at the same time from a rich perspective, we can manage to do some of that so I don't expect anything this year from a risk perspective to come off.
I expect all the opportunities to come on.
Going for it but the right range of that there's probably four to five contracts like that that will be coming up over the next 12 months.
In that range.
Gotcha, Alright, let me, let me sneak last one and.
You know and I I've asked about this a couple of times and it seems like maybe this is more of a backburner longterm, but any any update on meal delivery and how you guys are thinking about that or or should we just sort of backburner that for twenty-three and think about it more realistically down the road as that's something you guys might really go all in on things.
Sorry.
Oh, Neil Neil deliberate Oh, no so.
I feel really good about our plan for what we Wanna do and meal, we have a great new people that have taken out over and it's actually the platform that it's on is the platform that we have in our home division, which makes a lotta sense cause it's a referral base business. So they have that the tool.
Oh, the people have that skill set and we've appropriately we have the right partner and we have the right stinks picked to start to grow we have clear objectives. Okay ours that we have in 2023 and I expect that we will achieve that.
The the revenue and EBITDA contribution will be nominal.
As designed because we want to make sure that we continue to provoke this bottle and have the right mouse trap in place before we really accelerated but this year and I I do I look forward each quarter updating you and how we're doing it mainly mainly to show yeah. We're getting it. This is the right thing here's my conviction around what it's gonna do in 2000 2000.
For him beyond so it's gonna be a good year for me.
It actually could get to a point in 24, where you actually start talking about it as a better right well he'd better I say that I don't mean that from a from a hope perspective, I mean that from the team working on this and the discipline actions that we have in place the customer commit Smith commitments, we have we got to execute on that and I expect that we will.
All right very good. Thanks, Thanks, guys really appreciate it.
Thank you at this time I'd like to turn the floor back over to Mister Sampson for additional or closing comments.
I want to thank you for participating in our call. This morning, and your interest in motor care or update investor presentation. According supplemental decker posted on the Investor Relations website.
If you're interested in scheduling any follow up calls please contact Kevin E like shower head of Investor Relations.
We look forward to speaking with menu over the next number of days weeks months before report are for results in me. So thank you again for all the support and have a great day.
Ladies and gentlemen, thank you for your participation. This concludes today's event you may disconnect. Your lines are long after webcast at this time and enjoy the rest of your day.
[music].